2021 ISAKOS Biennial Congress ePoster
Complications In Simultaneous Bilateral Total Knee Arthroplasty; Is A Safe Procedure?
Tomas Alfredo Esteves, MD, Capital Federal, Buenos Aires ARGENTINA
Martin Buljubasich, MD, Buenos Aires ARGENTINA
Fernando Holc, MD, Caba ARGENTINA
Tomas Nicolino, MD, Buenos Aires ARGENTINA
Julian Costantini, MD, Buenos Aires ARGENTINA
Lisandro Carbó, MD, Bella Vista, buenos aires ARGENTINA
Hospital Italiano de Buenos Aires, Capital Federal, Buenos Aires, ARGENTINA
FDA Status Not Applicable
Summary
Simultaneous bilateral total knee arthroplasty has no statistical difference in postoperative complications compared with unilateral total knee replacement. We describe a statistically significant drop in postoperative hemoglobin and a higher proportion of transfused patients in the group of simultaneous bilateral total knee arthroplasty.
ePosters will be available shortly before Congress
Abstract
Background
There is controversy regarding various aspects of simultaneous bilateral total knee replacement at the same surgical time (SBTKR). We found in the literature, disparity in the postoperative outcomes and complications associated with the procedure.
Objective
To analyze retrospectively the need for blood transfusion after surgery and complications associated with total knee replacement according to the type of procedure (SBTKR or unilateral).
Methods
Retrospective cohort analytical study. We included 251 patients with severe knee osteoarthritis that were divided into two groups. 124 (49%) who underwent SBTKR and 127 who were performed unilateral total knee replacement (UTKR). Demographic data, days of hospitalization, complications within the first 90 days after surgery (thromboembolic events, superficial and deep infection, stiffness, death); and percentages of patients transfused with blood products during hospitalization were evaluated.
Results
There were no statistical differences in the analysis of postoperative complications in the first 90 días after surgery. In the SBTKR group, 8 patients (6.5%) presented some thromboembolic complication during the postoperative period, while this event was observed only in 2 patients (1.5%) from the other group. Regardless of the age, BMI, or ASA of the patient (OR 4.5; 95% CI 0.91-22.5; p = 0.06). The analysis showed a statistically significant drop in postoperative hemoglobin, on average of 0.8 g/dl, in the SBTKR patient group compared to the UTKR group. (95% CI 0,44-1,13; p<0,001). A higher proportion of transfused patients was observed in the SBTKR group (40%). (OR=7,12; 95% CI 3,3 - 16; p<0,001).
We analyzed the cause of postoperative transfusion of the transfused patients taking into account two parameters: hemoglobin less than 8 g/dl and the clinical need of the patients (symptoms of hypotension, decay, difficulty to rehabilitate without pain, dyspnea). 59 patients were transfused (50 in the SBTKR group and 9 in the other group). Of these, 19 patients (32.2%) did not meet any transfusion criteria.
Conclusions
We consider the SBTKR a safe procedure, which does not increase postoperative complications compared to the UTKR. Although there is an increase in blood loss in the SBTKR, it does not generate clinical symptoms of relevance.